Home > P&MM (Current issue) > News | Search

Prescribing & Medicines Management
Issue no 4, p3
July/August 2003

This article
Reprint
Photocopy


News summary


New contract for community pharmacists focuses on medicines use

Community pharmacists will play a greater role in repeat prescribing and promoting patient concordance under proposals in the new pharmacy contract. The proposed contract, which has been out for consultation since July, includes “essential services” which all pharmacists will be expected to offer from next April, “enhanced services” which the profession is expected to move towards and “additional services” which are those which meet a specific local need.

Dispensing and repeat prescribing are both classified as essential services and under the new contract pharmacists will routinely be expected to give patients advice about dispensed medicines and warn of any interactions.

Pharmacists will also be expected to work towards playing a greater role in the system of repeat prescriptions. In the future they will have the power to alter prescriptions to synchronise medicines and optimise dosage. They will also be able to recommend a date for a patient’s review with the GP.

The contract pulls back from insisting that pharmacists have to offer routinely a medicines-use review to all patients. That new role has been given “enhanced service” status. It was not made an “essential service” because pharmacist negotiators and the Government agreed that the work would require extra training and extra investment in premises to allow face-to-face consultations to take place.

Alastair Buxton, head of NHS services for the PSNC, which has been involved in the contract negotiations, said: “I would say that the medicines- use review, which is medicines management, is opening the door to getting pharmacists to talk to patients — to make that link between pharmacist and patient and the responsibility for medicines taking.”

The profession will have the chance to vote on the final proposals in a ballot in the autumn. Details about the pricing of the contract, which pharmacists will be balloted on separately, have yet to be published.

If the framework and funding are eventually approved the new contract will be introduced from April 2004.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal